Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Sep 12 - Sep 17
British Journal of Nutrition, 2018
Until rigorous clinical studies confirm its efficacy and safety, BPC-157 should be approached with caution and reserved for research settings rather than mainstream therapeutics
Open dialogue is essential to ensuring patient safety in an environment where access to unregulated compounds is increasingly common
Frank M
Product Specifications: Composition: Water for Injection, USP with 0.9% (9 mg/mL) Benzyl Alcohol, NF (bacteriostatic preservative) Volume: 30mL per sterile vial Container Type: Type I borosilicate glass vial with sterile rubber closure and aluminum overseal pH: 4.5 7.0 (per USP monograph) Osmolality: Hypotonic (approximately 0 mOsm/kg) Sterility Assurance Level: 10 (terminal steam sterilization) Bacterial Endotoxin: Bacterial Endotoxins Test Particulate Matter: Complies with USP Particulate Matter specifications FOR RESEARCH USE ONLY
GLP-1-based compounds work primarily through appetite suppression, and the weight loss they produce includes significant lean mass loss (approximately 40% of total weight lost is lean tissue based on STEP trial data)
US$ 25.60
US$ 23.76
US$ 20.21
US$ 25.36
US$ 26.35
US$ 20.88
US$ 22.06